Published: March 17, 2026
Industry Insights from Next Move Strategy Consulting
As healthcare systems increasingly embrace digital transformation, L&T Technology Services Limited has introduced an advanced AI-powered lung digital twin platform, signaling a significant shift in the evolution of the Digital Twins in Healthcare Market. Developed in collaboration with NVIDIA, the solution is designed to enhance respiratory diagnostics, surgical planning, and lung navigation through precision-driven, simulation-based technologies.
The newly launched platform integrates LTTS’ expertise in medical imaging, AI-enabled diagnostics, and connected healthcare systems with NVIDIA’s Physical AI infrastructure. By embedding advanced computational capabilities into clinical workflows, the platform enables clinicians to achieve higher levels of accuracy in diagnosing and treating complex respiratory conditions.
Through direct integration with CT imaging workflows, the solution utilizes deep learning to generate a comprehensive 3D digital twin of the lungs. This immersive representation allows clinicians to visualize critical anatomical structures including airways, blood vessels, lung lobes, and lesions and simulate procedural pathways for bronchoscopy and biopsy planning within a patient-specific digital environment.
The platform is powered by a suite of NVIDIA technologies that collectively enable high-performance clinical applications:
NVIDIA Omniverse and OpenUSD facilitate interactive 3D visualization and immersive exploration of lung anatomy. NVIDIA TensorRT enhances AI inference performance across high-speed clinical workflows. NVIDIA MONAI supports advanced medical image segmentation, enabling automated identification of key anatomical features such as tumors, vessels, and lung lobes.
Together, these capabilities transform static CT scans into dynamic, simulation-ready lung models, empowering clinicians to analyze anatomical relationships, plan surgical interventions, and navigate bronchoscopic procedures with improved precision.
The digital twin framework extends beyond visualization by supporting automated segmentation, volumetric analysis, and navigation path planning. This enables clinicians to reduce pre-operative planning time while improving procedural safety and overall patient outcomes.
According to Amit Chadha, the integration of engineering expertise with advanced AI infrastructure is paving the way for a new generation of biological digital twins that will redefine precision medicine. Similarly, David Niewolny highlighted the growing role of digital twins in enabling clinicians to visualize anatomy in 3D, simulate procedures, and plan interventions with greater confidence.
With respiratory diseases such as lung cancer and COPD continuing to rise globally, AI-driven digital twin technologies are expected to accelerate the transition from traditional imaging interpretation toward predictive, simulation-based healthcare delivery. This shift supports minimally invasive procedures and more personalized, data-driven treatment pathways.
From a market perspective, Next Move Strategy Consulting notes that the adoption of digital twins in healthcare is gaining strong momentum, driven by advancements in AI, medical imaging, and high-performance computing. The emergence of platforms like LTTS’ lung digital twin solution underscores a broader trend toward integrating real-time simulation and predictive analytics into clinical decision-making.
As healthcare providers seek to improve precision, efficiency, and patient outcomes, digital twin technologies are expected to become a foundational component of next-generation medical ecosystems.
The introduction of this AI-powered lung digital twin platform marks a pivotal development in the Digital Twins in Healthcare market. By enabling immersive visualization, procedural simulation, and enhanced diagnostic accuracy, LTTS is positioning itself at the forefront of innovation in precision medicine.
As the healthcare industry continues to evolve, such technologies are set to play a critical role in reshaping how diseases are diagnosed, treated, and managed ushering in a new era of intelligent, patient-centric care.
Source: Business Wire
Prepared by: Next Move Strategy Consulting
Tania Dey is a content writer specializing in transformation-led, insight-driven storytelling. She develops research-backed, high-impact content aligned with evolving business priorities, digital behavior, and audience expectations. Her work helps organizations sharpen value propositions, strengthen visibility, and communicate strategic intent with clarity and precision. Grounded in data-informed storytelling, she brings a strong focus on relevance, consistency, and measurable digital impact across platforms.
Debashree Dey is a senior content writer and communications specialist known for crafting audience-focused narratives and insight-driven content strategies. As a published manuscript author, she combines creative storytelling with strategic thinking to strengthen brand messaging, enhance visibility, and drive meaningful audience engagement across digital platforms. With a collaborative leadership approach, she contributes to high-impact communication initiatives that ensure consistency, clarity, and long-term brand value. Outside of work, she finds inspiration in creative projects, design exploration, and storytelling-driven ideas.
This website uses cookies to ensure you get the best experience on our website. Learn more
✖
Add Comment